The Problem – Many Americans struggle to afford the medications they need to manage chronic conditions and maintain their health. Access to affordable prescription drugs remains limited, especially in underserved communities where resources are stretched thin. Without adequate support, individuals may be forced to skip doses or forgo treatment entirely, exacerbating health disparities.
The Solution – Kentucky offers a solution to this issue by partnering with community organizations to help eligible individuals access reduced-cost prescription medications through the Kentucky Prescription Assistance Program (KPAP). KPAP helps patients navigate through existing discounted drug programs offered by manufacturers, retailers, and other sponsors. By leveraging existing community networks such as county health departments, hospitals, food pantries, and faith-based organizations, KPAP can substantially expand its reach without duplicating efforts or significantly increasing overhead. The program helps over 4,800 Kentuckians secure $47 million in free and reduced-cost medications in just one year – making it a national model for cost-effective prescription assistance.
Sample Legislation: The Kentucky Prescription Assistance Program was created through a line-item in Kentucky’s biannual budget bill. Even though there is no sample legislation, the example provides a successful model that can be replicated in other states.
The Problem – Diabetes management is a significant challenge for many low-income individuals, particularly those relying on Medicaid for healthcare. Continuous glucose monitors (CGMs), which are vital for managing blood glucose levels, are often not covered under Medicaid in many states, leaving patients without access to a crucial tool. Without CGMs, patients are more likely to experience complications from poorly controlled diabetes, leading to costly medical interventions and long-term health consequences.
The Solution – Arkansas has addressed this gap by passing legislation that mandates Medicaid coverage for CGMs, ensuring that low-income residents have access to this essential diabetes management tool. CGMs help patients maintain better control over their blood glucose levels, reducing the likelihood of complications and lowering healthcare costs. Studies show that the adoption of CGMs can save Medicaid an estimated $4,000 per patient over nine months compared to patients who do not use the technology. By including CGMs in Medicaid coverage, states can protect their most vulnerable residents, improve diabetes management, and reduce avoidable healthcare expenses.
The Problem – The obesity epidemic, a major contributor to diabetes, continues to strain healthcare systems and worsen public health outcomes. While obesity is linked to over 200 comorbidities including diabetes, current approaches often lack a long-term, comprehensive strategy. Medicaid programs are limited in their coverage of effective treatments for obesity, including nutritional therapies, behavioral interventions and pharmacological options. Additionally, obesity stigma creates barriers for individuals seeking care, further exacerbating health disparities.
The Solution – To effectively combat obesity and prevent diabetes, states must implement comprehensive policies that ensure Medicaid coverage for the full spectrum of of obesity treatments. This should include behavioral interventions like the Diabetes Prevention Program (DPP), intensive behavioral therapy (IBT), and medical nutritional therapy (MNT), as well as coverage for anti-obesity medications as well as bariatric surgery. Addressing obesity stigma in healthcare settings is also critical to ensure patients feel supported and can access the care they need without bias or judgment. By expanding treatment options and reducing stigma, states can promote sustainable solutions that address the root causes of obesity and diabetes and ensure equitable access to treatment for all individuals, regardless of income or background.
The Problem - Type 1 diabetes (T1D) is the second-most common chronic disease affecting school-aged children, creating challenges in managing blood glucose, which impacts children’s emotional, social, and academic well-being. T1D management requires a strict regimen involving insulin and monitoring, which is draining for students and affects school participation. Additionally, a lack of emergency preparedness for severe hypoglycemia, as well as delayed diagnosis due to nonspecific symptoms, heightens risks for affected children.
The Solution - Ensuring a supportive school environment involves providing children with access to necessary medical supplies, education on T1D management, and emergency preparedness. Undesignated glucagon—a life-saving medication for low blood sugar emergencies—should be readily available in schools to address hypoglycemia effectively. Schools should also act as educational hubs, offering information on T1D and T1D screening to families, empowering them to recognize symptoms early and manage the condition proactively.
DOWNLOAD THE HANDBOOKSee how your state scores on the impact of diabetes and what, if any, legislative action has been taken to address the problem. Click your state below!
Legislation Scorecard
7.9% with Diabetes
6.8% with Diabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
7.4% with Diabetes
7.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
13.4% with Diabetes
8.9% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.0% with Diabetes
7.4% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.5% with Diabetes
9.4% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.7% with Diabetes
8.8% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
7.6% with Diabetes
5.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
12.0% with Diabetes
9.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
6.6% with Diabetes
6.6% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.2% with Diabetes
6.6% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.8% with Diabetes
11.6% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.4% with Diabetes
6.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.9% with Diabetes
6.3% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.7% with Diabetes
10.0% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
11.4% with Diabetes
8.8% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.7% with Diabetes
80% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.7% with Diabetes
6.6% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
11.0% with Diabetes
8.2% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.0% with Diabetes
9.8% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.6% with Diabetes
10.1% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
11.2% with Diabetes
10.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.8% with Diabetes
5.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.4% with Diabetes
11.9% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.1% with Diabetes
6.2% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.7% with Diabetes
7.0% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.2% with Diabetes
7.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.2% with Diabetes
7.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
12.9% with Diabetes
6.6% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
7.9% with Diabetes
7.0% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.5% with Diabetes
7.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.8% with Diabetes
10.6% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.7% with Diabetes
6.0% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
12.9% with Diabetes
7.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
11.2% with Diabetes
7.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.5% with Diabetes
11.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
12.1% with Diabetes
9.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.8% with Diabetes
7.3% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.4% with Diabetes
8.1% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.2% with Diabetes
8.0% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
7.3% with Diabetes
9.0% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.3% with Diabetes
12.8% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
.png)
Legislation Scorecard
10.5% with Diabetes
9.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
10.1% with Diabetes
9.8% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
8.2% with Diabetes
9.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
6.5% with Diabetes
6.5% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
9.3% with Diabetes
8.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
6.6% with Diabetes
9.7% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn't available.
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Provides that the State Board of Education shall develop type I diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Legislation Scorecard
12.7% with Diabetes
7.3% with Prediabetes
Diabetes Action Plan
Insulin Copay Cap
Diabetes Supply Copay Cap
Emergency Access to Insulin
Rebate Pass-through
Comprehensive Medicaid Coverage for CGM
Anti-Obesity Medication Medicaid Coverage
Undesignated Glugacon in Schools
Type I Screening Education
Copay Accumulator Ban
First Dollar Coverage for Diabetes Care
Yes
No
Working
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Indicate which one: Yes (purple text). No (red text), or In progress (Yellow text).
Requires pharmacy benefit managers (PBMs) to pass through drug rebates to patients at the point of sale during the deductible period, lowering the cost of prescription drugs.
Ensures that beneficiaries with diabetes have access to Continuous Glucose Monitors (CGM) and related supplies as part of their healthcare benefits.
Limits the amount individuals with diabetes have to pay out-of-pocket for insulin by imposing a maximum limit on patient cost-sharing.
Set a maximum limit on out-of-pocket costs for various diabetes supplies, such as glucose test strips, lancets, insulin pumps, and continuous glucose monitors (CGMs).
Prohibit health insurers and PBMs from applying copay accumulator programs which prevent third-party copay assistance from counting toward a patient's deductible or out-of-pocket maximum.
Patient cost-sharing benefits begin without requiring the insured individual to pay a deductible or other out-of-pocket expenses first, ensuring that essential diabetes-related services, treatments, and medications are covered immediately, minimizing financial barriers for patients.
Permits pharmacists to dispense a 30-day supply of insulin in emergency situations where the prescriber isn’t available.
Strategic frameworks developed by state entities that include specific goals, strategies, and initiatives aimed at prevention, early detection, better management, and improved healthcare services for individuals living with and at risk for diabetes.
Provides that the State Board of Education shall develop type 1 diabetes informational materials for parents and guardians of students to receive upon elementary school enrollment and/or the school's student handbook.
Permits public and private schools to stock a supply of undesignated ready-to-use glucagon to ensure the safety of schoolchildren with diabetes.
Legislation establishing state Medicaid obesity treatment coverage includes the defined standards of care by the medical community including behavioral, dietary counseling, surgical, and pharmacological care.
.png)
